The microbiome of diabetic foot ulcers : a comparison of swab and tissue biopsy wound sampling techniques using 16S rRNA gene sequencing by Travis, J. et al.
RESEARCH ARTICLE Open Access
The microbiome of diabetic foot ulcers: a
comparison of swab and tissue biopsy
wound sampling techniques using 16S
rRNA gene sequencing
J. Travis1, M. Malone2,3,4, H. Hu5, A. Baten6, K. Johani4,7, F. Huygens8,9, K. Vickery5 and K. Benkendorff1,10*
Abstract
Background: Health-care professionals need to collect wound samples to identify potential pathogens that
contribute to wound infection. Obtaining appropriate samples from diabetic foot ulcers (DFUs) where there is a
suspicion of infection is of high importance. Paired swabs and tissue biopsies were collected from DFUs and both
sampling techniques were compared using 16S rRNA gene sequencing.
Results: Mean bacterial abundance determined using quantitative polymerase chain reaction (qPCR) was
significantly lower in tissue biopsies (p = 0.03). The mean number of reads across all samples was significantly
higher in wound swabs ðX = 32,014) compared to tissue (X = 15,256, p = 0.001). Tissue biopsies exhibited greater
overall diversity of bacteria relative to swabs (Shannon’s H diversity p = 0.009). However, based on a presence/
absence analysis of all paired samples, the frequency of occurrence of bacteria from genera of known and potential
pathogens was generally higher in wound swabs than tissue biopsies. Multivariate analysis identified significantly
different bacterial communities in swabs compared to tissue (p = 0.001). There was minimal correlation between
paired wound swabs and tissue biopsies in the number and types of microorganisms. RELATE analysis revealed low
concordance between paired DFU swab and tissue biopsy samples (Rho = 0.043, p = 0.34).
Conclusions: Using 16S rRNA gene sequencing this study identifies the potential for using less invasive swabs to
recover high relative abundances of known and potential pathogen genera from DFUs when compared to the
gold standard collection method of tissue biopsy.
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Background
Diabetic foot ulcers (DFUs) are associated with morbidity
and mortality, and are a frequent cause of hospitalisation
[1]. The majority of DFUs develop due to loss of protective
sensation and/or reduced peripheral perfusion. Damage to
the protective skin envelope enables entry of microorgan-
isms which colonise host tissue. This may lead to further
microbial replication and damage to host tissue which can
manifest as a clinical infection [2]. Alternatively, the colon-
isation of microorganisms may lead to a stable microbial
community, which does not elicit a host response, but con-
tributes to several ill-defined mechanisms keeping the
wound in a “chronic” non-healing state [3]. In either case,
accurately identifying the microbiome within DFUs could
enhance treatment by enabling targeted therapeutic regi-
mens, which include the use of systemic or topical anti-
microbial therapies in order to augment sharp debridement.
Historically, microorganisms associated with samples
collected from all aspects of human disease have been
identified in clinical and research laboratories using
culture-dependent techniques, which employ traditional
growth media and incubation conditions. These tech-
niques are now acknowledged as being selective for mi-
croorganisms which thrive under the physiological and
nutritional constraints of the microbiology laboratory
[4]. Fastidious microorganisms are rarely isolated from
culture, as they require specific growth conditions and
identification techniques that are beyond the scope of
most clinical laboratories. Therefore, many microorgan-
isms that may be of clinical significance within wounds
can remain uncultured and results may not accurately
reflect the wound microbiome [5–7]. A review discuss-
ing classification, epidemiology and microbiology of skin
and soft tissue infections, including diabetic foot ulcers,
presented a summary of organisms isolated from 271
DFUs using culture techniques [8]. Percentages of com-
mon facultative aerobic isolates included Staphylococcus
spp. (27%), Pseudomonas spp. (20%) and Enterobacteria-
ceae (11%). Anaerobes were isolated in 1.9% of the 271
wounds and the low percentages of anaerobes may be
the result of a failure to isolate these organisms using
traditional culture methods [9].
Next generation DNA sequencing, using variable re-
gions of the bacterial 16S rRNA gene, has been success-
fully applied to provide an extended view of the chronic
wound microbiome [4, 5] and more recently of infected
tissues from DFUs [10]. The sampling techniques utilised
in these studies have varied, with some researchers prefer-
ring wound swabs [11] rather than tissue biopsies or de-
bridement material [10, 12]. The major limitation to
obtaining tissue specimens in the form of a punch biopsy
is that the procedure is more invasive, requires a skilled
clinician, and in the absence of peripheral neuropathy,
local anaesthesia. Furthermore, where study objectives
require longitudinal sampling of wounds, obtaining tissue
biopsies can present a challenge. Ethical implications must
be considered, as regular sampling would be required for
longitudinal studies, which could be distressing for partici-
pants, may affect wound healing and generally influence
decisions to participate in the study.
In contrast, using a swab to obtain material from the
surface of a wound is not invasive and does not involve
any of the above sampling technique disadvantages. A
number of research groups have routinely utilized
wound swab samples for DNA sequencing studies in
preference to tissue biopsies or curettage [4, 13, 14]. The
limitations of collecting wound swabs has been investi-
gated using cultivation-based studies which have re-
ported low concordance of isolated bacteria when
compared to tissue specimens [15, 16]. A large, multi-
centre study recruiting 400 participants with suspected
infected diabetic foot ulcers from 25 sites within England
investigated the concordance of cultured swabs collected
using the Levine method [17] and tissue biopsies. Tissue
sampling and culture methods were not standardised
across laboratories. Overall there were significant differ-
ences in the pathogens reported from 395 paired tissue
biopsies and swabs, with tissue biopsies isolating more
pathogens than swabs [18–20]. This evidence base has
therefore led many expert groups in the area of diabetic
foot disease to promote the use of tissue biopsy or curet-
tage as the gold standard sampling method for detecting
the pathogens in infected DFUs [2, 21, 22]. Nevertheless,
low concordance between sampling methods does not
imply that one method is superior to the other, as the
question still remains as to which method recovers a
better representation of the wound microbiome and if
swabs can be used to recover the majority of known and
potential pathogen genera from DFUs.
Limited studies have been undertaken to directly compare
concordance between microorganisms identified from
wound swabs versus tissue biopsies using 16S rRNA gene
sequencing. However, some researchers have utilised wound
swab samples to produce robust, quality outcomes [4, 11,
23]. The microbiome of five samples from the inner elbow
of healthy human skin tissue using tissue biopsies, skin
scrapings and swabs was investigated [23] and authors
found that the dominant microorganisms were identified
equally well across the three collection methods. Conversely,
other researchers have reported that tissue specimens reveal
significantly more known and potential pathogen genera
(p= 0.03) relative to those found in swabs [24].
These contrasting results provide the context as to why
further research is required for understanding whether dif-
ferent sampling methods such as wound swabs or tissue bi-
opsies produce comparable outcomes. With the increased
utilisation of genomic approaches, including next gener-
ation DNA sequencing, there are clear logistical advantages
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to utilising wound swabs if the data is equivalent to, or just
as informative as, tissue biopsies. The ability to collect sam-
ples quickly and easily with minimal training requirements
could facilitate greater participant recruitment (because no
contra-indications exist for collection of wound swabs
when compared to tissue biopsies), and should enable tem-
poral analysis on a larger scale. Therefore, the aim of this
study was to investigate the concordance between paired
swab and tissue samples from DFUs using 16S rRNA gene
sequencing, and to determine if either or both sampling
methods provide useful and clinically relevant information.
Secondary aims were to compare information regarding
microbial diversity and community structure of DFUs,
knowledge of which may be insightful for researchers inves-
tigating therapeutic and diagnostic measures of these recal-
citrant chronic wounds.
Results
Total bacterial abundance and number of reads
The mean number of copies of the 16S rRNA gene/μl
was significantly higher in swab than tissue biopsy sam-
ples (p = 0.03, Table 1). The range in total abundance
was greater in tissue than swab samples (Fig. 1.a, Supple-
mentary Table S1 Additional File 1). The ratios of the
copies of 16S/18S rRNA gene indicated that tissue biop-
sies had a higher ratio of 16S rRNA gene copies relative
to swabs with results of the Wilcoxin paired t-test sig-
nificant (p = 0.004 Table 1, Fig. 1.b). The mean number
of reads obtained from the swab samples was signifi-
cantly higher than those from tissue samples (p = 0.001,
Table 1). Rarefaction analysis established a suitable cut-
off of 1500 reads for a standardised comparison and
reads < 1500 were excluded from further analysis. No
significant correlation was detected between swab and
tissue biopsy samples for total abundance or number of
reads, indicating no concordance in the order that swabs
and tissue from the same DFU were ranked (Supplemen-
tary Table S2 Additional File 1).
Species richness and diversity
Based on rarefaction for 1500 reads the bacterial richness
derived from the number of distinct operational taxa-
nomic units (OTUs), varied from a minimum of 11 and a
maximum of 41 across all swab samples and from a mini-
mum of 14 to a maximum of 62 across all tissue samples
(Fig. 1.c, and Supplementary Table S3 Additional File 1).
The mean rarefied bacterial richness (Table 1) was signifi-
cantly higher (p = 0.0003) in tissue biopsy samples. The
standardised species diversity (Shannon’s H index) was
also higher in tissue (Fig. 1.d) and the paired t-test con-
firmed a significant difference in diversity (p = 0.009) be-
tween the two sampling techniques (Table 1).
Common genera with known pathogens
The mean relative abundance of bacteria from genera
with known and potential pathogens was frequently
higher in the swab samples compared to tissues (Table
1, Fig. 2.a) and this difference was significant for
Staphylococcus spp., Streptococcus spp., Corynebacterium
spp., Enterobacteriaceae and the obligate anaerobe





w/t value1 p value
No. of reads a 32,014(±16,068) 15,256(±16,699) − 162 0.001*
dAbundance b 564.7(±566.9) 266.5(±535.5) − 108 0.03*
16S/18S ratio 0.201(±0.35) 1.06(±1.08) 150 0.004*
Bacterial richnessc 25.1 (±8.2) 38(±11.7) 4.423 0.0003*
Shannon’s diversity 1.8(±0.58) 2.4(±0.78) 2.921 0.009*
dStaphylococcus spp. 49.3(±58.2) 14.4(±19.3) − 158 < 0.001*
dStreptococcus spp. 32.6(±39.3) 12.9(±37.9) − 131 0.003*
dEnterococcus spp. 7.3 (±8.0) 9.2(±22.4) − 57 0.224
dCorynebacterium spp. 42.9(±35.8) 18.3 (±20.0) − 128 0.015*
dEnterobacteriaceae 49.3 (±49.1) 24.7(±35.5) − 120 0.024*
dPseudomonas spp. 11.8(±26.9) 16.6(±38.5) 8 0.776
dAnaerococcus spp. 39.1(±35.9) 17(±26.1) − 132 0.012*
dFinegoldia spp. 20.8(±15.6) 17.8(±22.4) −32 0.535
1 As most of the data analysed was nonparametric, Wilcoxin signed rank tests were used except for bacterial richness and Shannon’s diversity data which were
subject to paired t-test analyses
a reads in filtered OTU table (> 0.05%)
b no. of copies of 16S rRNA gene/μl
c Bacterial richness rarefied to 1500 reads
d square root transformed data
* Significant results (p < 0.05)
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Anaerococcus spp. (p < 0.05, Table 1). In contrast, there
were no significant differences in the mean relative
abundances of Enterococcus spp., Pseudomonas spp., and
Finegoldia spp., in swabs and tissue samples. Results of
the Spearman rank correlation indicate that none of the
pathogens were significantly correlated in swabs and tis-
sue from the same DFU (Supplementary Table S2 Add-
itional File 1).
Based on presence or absence in each sample, the per-
centage of samples in which the genera of known species
specific pathogens were detected is illustrated in Fig. 2.b.
Staphylococcus spp., was found in all 20 swab samples,
along with Corynebacterium spp., Anaerococcus spp., and
Finegoldias spp. By comparison, recovery of Staphylococ-
cus spp., from the tissues samples was 85%, whereas 70%
of tissue samples contained Corynebacterium spp., 50%
contained Anaerococcus spp., and 90% Finegoldia spp.
Conversely, Pseudomonas spp. was identified in 45% of tis-
sue samples compared to 30% of swab samples.
Bacterial profile and additional organisms identified in
swabs and tissue biopsies
Relative abundances of bacteria in genera containing
known pathogens and other bacteria (Fig. 3) demonstrate
very little concordance between swab and tissue sample
pairs. Nevertheless, some samples do have similar popula-
tions of potential pathogens; for example both swab 3 and
tissue 3 are dominated by Streptococcus spp., Corynebac-
terium spp., Staphylococcus spp., Finegoldia spp. and
Anaerococcus spp. Paired swab and tissue samples from
wound 4 recovered Finegoldia spp., Anaerococcus spp. and
Enterobacteriaceae, and wound 6 samples have high abun-
dances of Streptococcus spp. and very low abundances of
Enterobacteriaceae, Corynebacterium spp. and Anaerococ-
cus spp. However, other pairs are more variable with dif-
ferent bacteria in swabs and tissue, including wound swab
sample 12, which had 25% abundance of Anaerococcus
spp., but this organism was not identified in the tissue bi-
opsy sample. On the other hand the tissue sample
Fig. 1 Bacterial abundance (qPCR) and sequence metrics for paired swab and tissue samples N = 20: a) number of copies of 16S rRNA gene /μl
(sqrt transformed); b) swab and tissue biopsy 16S/18S ratios; c) richness (number of distinct OTUs) rarefied to 1500 reads; and d) standardised
Shannon’s H index
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recovered 19% Staphylococcus spp., which was identified
at an abundance of only 1% in the swab. There are many
other examples of lack of concordance in the relative
abundance of potential pathogens and other bacteria iden-
tified from the paired samples (Fig. 3).
Other bacterial genera (Fig. 3) and families identified from
the samples used in this study have been listed (Supplemen-
tary Table S4 Additional File 2) with over 30% of the de-
scribed organisms present in both swabs and tissue biopsies.
The relative abundance of these additional organisms varied
between samples (Fig. 3), and the majority of distinct OTUs
were present at less than or equal to 1% of total OTUs in
both swabs and tissue biopsies. Obligate anaerobes Prevo-
tella spp., Bacteroides spp., Porphyromonas spp. and Peptos-
treptococcus spp. were present in relative abundances of up
to 3% in tissue and 4% in swab samples (Supplementary
Table S4 Additional File 2). Archaea were identified from
tissue samples only, in relative abundances of up to 1%.
Community composition
Multivariate permutational analysis of variance (PERMA-
NOVA) on the 4th root transformed reads confirmed
Fig. 2 Comparison of common known and potential pathogen genera in swab and tissue biopsy samples: a) mean and standard deviation of
square root transformed relative abundance of pathogens, * p < 0.05; and b) percent of swab and tissue samples in which each pathogen
genera occurred
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there was a significant difference in the overall bacterial
communities that were sequenced from swabs compared
to tissue biopsies (Pseudo F = 18.58, p = 0.0001 from 9918
permutations). The principal co-ordinate ordination
(PCO) plot reveals clear separation of the swab and tissue
samples along PCO1 and substantial variability between
the communities of bacteria found in DFUs within each
sampling method along PCO2 (Fig. 4). Vector overlay
based on Pearson correlation (r ≥ 0.8) indicates that tissue
samples are associated with increased numbers of rela-
tively uncommon organisms including the Archaea family
Cenarchaeaceae, and bacteria including the species Eliza-
bethkingia meningosepticum, the order Acidimicrobiales,
Balneola spp. and Rhodothermaceae families (Fig. 4).
Swabs are characterised by relatively high loads of Prevo-
tella spp. (Fig. 4). Swabs and tissue are clustered in separ-
ate distinct communities indicating no concordance
between the collection methods. RELATE analyses based
on matched resemblance matrices for swabs and tissue bi-
opsy samples confirmed that there was no significant
multivariate correlation between bacterial communities in
paired samples (sample statistic Rho = 0.043, p = 0.34 and
9999 permutations of which 3395 were greater than or
equal to Rho). The dendogram indicated no pairing of
swabs and tissue bacterial communities from the same
ulcer (Supplementary Table S5 Additional File 3).
Discussion
Using 16S rRNA gene sequencing, swabs of DFUs col-
lected using the Levine method were found to effectively
detect bacteria in genera with known pathogens, at a
similar or higher frequency to those recovered from tis-
sue biopsy samples. Both collection techniques identified
the same range of pathogenic genera, although signifi-
cant differences in relative abundances were detected for
some genera and low concordance was displayed be-
tween paired swab and biopsy samples overall. Swabs re-
covered higher relative abundances of common bacteria
from genera with known pathogens, whereas uncommon
organisms (0.05 to 1% of relative abundance) were more
prevalent in tissue biopsies. Therefore, from a clinical
perspective, the results of this study suggest that non-
invasive swabs are suitable for detecting potential patho-
gens in DFUs, using 16S rRNA gene sequencing tech-
niques, whereas from a research perspective the higher
species richness and diversity in tissues may be of
interest.
A higher proportion of wound swab samples detected
clinically relevant bacteria from genera of known patho-
gens, suggesting that bacterial profiling using 16S rRNA
gene sequencing from wound swabs could be more reli-
able for pathogen detection than sequencing tissue biop-
sies of the wounds. Although other studies have
reported a higher number of pathogens isolated from tis-
sue biopsies versus swabs using traditional culture [18–
20], the multicentre study by Nelson et al., (2016) also
included a small sub study comparing 12 paired swab
and tissue samples using PCR [19]. These authors found
that in contrast to the results from culture techniques,
more pathogens were identified from swabs than tissue
samples, when both were analysed by PCR [19]. This
lends support to our study conclusions using DNA
Fig. 3 Relative abundance of common known and potential pathogen genera and other bacteria identified in each paired swab and tissue
biopsy sample
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sequencing. However, these results are in contrast with a
study by Dunyach-Remy et al., (2014) using polymerase
chain reaction denaturing gradient gel electrophoresis
(PCR-DGGE) [24], whereby significantly greater propor-
tions of known pathogens were identified in DFU tissue
samples (87%) compared to swab samples (58%), with no
pathogenic bacteria detected in 9 of the 20 swab sam-
ples. Polymicrobial infections were identified in 16 of the
20 tissue biopsy samples. PCR-DGGE does not provide
the same depth of information for pathogen identification
as next generation sequencing. Forty seven species were
identified from 20 paired DFU samples in the PCR-DGGE
study [24], compared to a richness of 185 OTUs repre-
sented over 20 paired samples from the present study using
16S rRNA gene sequencing. Furthermore, P. aeruginosa,
Staphylococcus spp. (other than S. aureus), Corynebacter-
ium spp. and some members of the Enterobacteriaceae
family were not included as pathogens in the previous
DGGE study, but were described as intermediate or com-
mensal flora [24]. A study by Frank, Wysocki [25] com-
pared fifteen paired swabs and tissue biopsies from mixed
wound types and aetiologies using 16S rRNA gene sequen-
cing and employing an ARB database [26]. Similar to our
study, these researchers detected Streptococcus spp. more
frequently in swabs, and also found that the percentage of
occurrence was higher in swabs for Enterococcus spp. [25].
However, in contrast to our results, Frank et al. (2009) de-
tected a higher occurrence of S. aureus, Corynebacterium
striatum and Anaerococcus lactolyticus in tissue samples
compared to swabs. These previous studies comparing
wound swabs and tissues used different DNA extraction
and bacterial profiling procedures to those used in the
current study, with two papers not describing the swab col-
lection method. Our study demonstrates that by using the
Levine method with 16S rRNA gene bacterial profiling,
swabs can capture a large microbiome from DFUs and in
particular, provide good recovery of clinically relevant path-
ogens when compared to tissue biopsies.
Despite recovering similar pathogens, there was very
low concordance in the bacterial profiles between paired
swabs and tissue biopsies based on correlation data. The
multivariate principle coordinate ordination (PCO)
showed a clear segregation of swabs and tissue samples,
with no pairing according to the wound of origin. This
indicates that the two collection techniques produced
different sample populations of microbes. It is possible
that the observed differences in the swab and tissue bi-
opsy sample communities could have resulted from the
Fig. 4 Principle co-ordinate ordination of the bacterial communities from paired DFU swab and tissue biopsies. A Bray Curtis similarity matrix was
generated from 4th root-transformed OTUs. Vector overlay is based on Pearson correlation (r ≥ 0.8) with the specific bacteria listed that
correspond to the vectors in each direction. Relative abundances of bacterial communities contributing to the disparity along PCO2 were equal
to or less than 1% of total reads (Supplementary Table S4 Additional File 2)
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different kits used to extract DNA from the swab and
tissue biopsy samples. Further studies should be under-
taken using an orthogonal design with standardised ex-
traction methods optimised for both sample types. In
this study we standardised the general procedure, how-
ever, the lytic mixtures used were optimised for the type
of sample. Procedural artefacts could be created by using
the same reagents if not suited to the sample. For ex-
ample a harsher lytic mix may extract bacterial DNA
well from tissue but destroy more bacterial DNA in
swabs. Conversely a milder lytic mix may not penetrate
the tissue sample well and result in under-representation
of wound pathogens.
Uncommon organisms identified only in the tissue
samples in abundances of up to 1% of total tissue reads
included Archaea, which have been previously found in
the human gut [27, 28]; cyanobacteria (blue-green algae
including C. symbiosum identified at a similarity of
100%) usually found in water and produce metabolites
potentially toxic to humans and animals [29]; Chloroflexi
(green non-sulphur bacteria) previously reported as an
open sea water residing bacteria that can degrade terres-
trial organic matter [30]; Deinococci, which are radiation
tolerant bacteria and have been described as extremo-
philic, as the organisms are very resistant to environ-
mental hazards [31]; the hyperthermophilic bacteria
Thermotogaceae family which are also extremophiles,
preferring temperatures in excess of 45 °C [32]; the Bal-
neolaceae family in the Bacteroidetes phylum [33] and
the Rhodothermaceae family also within the Bacteroidetes
phylum, which are known as environmental bacteria. The
order Acidomicrobiales in the Actinobacteria phylum are
found in mixed environments including soil, marine and
land water [34]. None of these bacteria were detected in
tissue positive controls with reads > 1 (Supplementary
Table S7 Additional File 5), and they have not been previ-
ously documented in association with human wound in-
fections. It remains possible that some of the distinct
OTUs with low relative abundance are contaminants as
they have been previously reported from DNA extraction
kits [35]. Alternatively they may play an as yet unidentified
role in the establishment or maintenance of complex bio-
film communities. Therefore, the identification of these
environmental organisms in tissue biopsies cannot be
disregarded as the microbiome of DFUs is complex, and
subsequent studies may confirm or otherwise their signifi-
cance in maintaining chronicity in these wounds. Further
studies aimed at characterising these organisms could be
undertaken using tissue samples to ensure maximum
representation in the microbiome.
Elizabethkingia meningoseptica was identified only
from tissue samples at a similarity score of 100%. This
bacterium has been previously associated with severe in-
fections, especially in immunocompromised individuals,
although the pathogenicity of E. meningoseptica has not
been described in diabetic wounds [36]. Cutibacterium
acnes formerly Propionibacterium acnes [37] resides in
sebaceous follicles on the human skin and was only re-
covered from DFU tissue biopsies (at a similarity score
of 100%) but not swab samples. This organism has been
previously detected in DFUs [38, 39]. Obligate anaerobes
Prevotella spp., Peptoniphilus spp., Peptostreptococcus
spp., Porphyromonas spp. and Bacteroides spp. were re-
covered from both swabs and tissue samples and these
organisms are known to be involved in human infec-
tions, including wounds [38, 40–42].
There was significantly more eukaryotic DNA present
in swab samples relative to tissue biopsy samples (Table
1) with many swabs heavily bloodstained after collection
from participants. Glassing et al., (2015) discussed com-
petitive inhibition due to large amounts of human DNA
on low bacterial biomass samples which can interfere
with applications including PCR and 16S rRNA sequen-
cing [43]. A higher ratio of bacterial to human DNA in
the tissue biopsy samples in our study may have contrib-
uted to the increased richness and diversity in tissue bi-
opsy samples relative to swab samples. In future
sampling, care should be taken to reduce the amount of
blood on swab samples.
Macro-scale spatial variation, whereby organisms
within the wound are non-uniformly distributed, may
lead to sampling limitations and therefore differences in
community profiles [44–46]. During sample collection in
this study sampling positions of the swab and tissue bi-
opsy within each wound differed as the tissue was col-
lected from an unswabbed area. Wound biopsies were
collected from a single defined point at the wound edge.
By comparison, swabs were rotated to cover more
wound surface area. More specifically, using the Levine
method, swabs are rotated within a 1 cm2 area and to a
depth of at least 3mm depending on the softness of the
wound tissue to enhance recovery of the exudate fluid [47].
The greater sample area could be one reason why we found
a higher number of reads and pathogens in the swabs com-
pared to biopsies. Nevertheless, while biopsies may only
sample one relatively small area, they recover microbes that
penetrate deeper into tissue. In a study using confocal laser
scanning microscopy (CLSM) on tissue biopsies, P. aerugi-
nosa was detected deeper into the tissue relative to S. aur-
eus [45]. The association with the surface of wound beds
may contribute to why our swab samples had a significantly
higher mean relative abundance of Staphylococcus spp. than
tissue samples, whereas Pseudomonas spp. displayed a non-
significant trend towards a higher mean relative abundance
in tissue biopsies relative to swabs and were found in nine
of 20 samples in tissue but in only six swab samples. Com-
posite samples, whether swabs or tissue biopsies, from dif-
ferent sites within a wound, may provide a more consistent
Travis et al. BMC Microbiology          (2020) 20:163 Page 8 of 14
and reliable representation of the overall wound micro-
biome [44].
Despite an apparent lack of concordance in the spe-
cific communities detected in paired swabs and tissue bi-
opsies, both methods were able to recover a comparable
and diverse range of DFU pathogens. A similar compos-
ition of pathogenic and potentially pathogenic organisms
in DFUs were reported from a retrospective, multicentre
study which used the 16S rRNA gene to sequence and
investigate the microbiome of 910 debrided tissue sam-
ples from DFUs [12]. Of the seven most abundant bac-
terial genera (which accounted for approximately 60% of
the taxa reported from the retrospective study), all were
identified in both swab and tissue biopsy samples from
our study. The remaining genera identified and de-
scribed in the multi-centre study [12], were also identi-
fied from a number of tissue biopsy and swab samples
used in this study which indicates that our 20 swab and
tissue biopsy samples taken from a high risk foot clinic
in Sydney, Australia are generally representative of what
has been detected in tissue biopsied from a large number
of DFUs in other worldwide locations. This information
provides confidence in the use of swab samples for fu-
ture studies aiming to identify the microbiome in DFUs.
Conclusions
Using 16S rRNA gene sequencing, this study has investi-
gated the concordance of paired swab and tissue biopsy
samples from diabetic foot ulcers. The results of univariate
and multivariate analyses of identified microbes indicate
low concordance using the two collection techniques,
which could be the result of within wound macro-scale
spatial variation or different lytic mixtures used to extract
bacterial DNA. Significantly higher relative abundances of
some pathogens were identified in swabs compared to tis-
sue biopsies, although biopsies produced richer micro-
biomes. From a practical and ethical viewpoint, wound
swabs are preferable to tissue biopsies. The high represen-
tation of genera containing potential pathogens identified
from non-invasive swabs suggests that researchers profil-
ing wound microbiomes could readily collect swab sam-
ples using the Levine method, with confidence that the
detection of common pathogenic genera will be similar to
those obtained from tissue biopsies. Should standard
microbiology laboratories adopt molecular based tech-
niques, then wound swabs may prove highly beneficial for
clinical practice, minimising the requirement to obtain an
invasive tissue biopsy. Swabs collected using the Levine
method can easily be used to provide intra- wound and
serial wound samples with minimal or no discomfort to
the patient and also facilitate between study comparisons
using a standardised sample collection technique. From a
research perspective further understanding of the micro-
biome of the DFU is crucial, to facilitate identification of
specific organisms which could be responsible for
prolonging the healing process. This study indicates that
the microbial diversity and community structure obtained
from tissue samples may be more representative of the
microbiome from the deeper wound bed in DFUs.
Methods
Participants and sample collection
To investigate the microbiomes captured by swabs and
tissue biopsies 20 patients presenting with an active
DFU were recruited from a tertiary referral hospital (Liv-
erpool Hospital High Risk Foot Service Sydney
Australia) over a six-month study period. At the time of
presentation, DFUs were either clinically infected as per
the Infectious Disease of America guidelines for diabetic
foot infection (DFI) [2] or chronic, non-healing and not
responding to routine care including offloading, revascu-
larisation and compression therapy. All participants had
been diagnosed with peripheral neuropathy. One partici-
pant had been diagnosed with ischaemic heart disease
(IHD). Participants receiving systemic or topical antimi-
crobials two weeks prior to this study were not included.
Demographic data is provided in Supplementary Table
S6 Additional File 4.
Ethics approval for the study was granted by the South
West Sydney Local Health District Research and Ethics
Committee (HREC/14/LPOOL/487, SSA/14/LPOOL/
489) and all participants provided informed written
consent.
Collection of tissue biopsies
Tissue biopsies 3 mm wide and 10mm deep were col-
lected using a biopsy punch from the edge of each DFU
after cleansing the wound with 0.9% NaCl. After aseptic
removal, tissue biopsy samples were washed in a PBS
bath to remove coagulated blood and surface bacteria.
Samples were sectioned transversely into a 1.5 mm frag-
ment and placed into approximately 100 μl of RNAlater
(Sigma-Aldrich Australia cat. no. R 0901) for 24 h at 4 °C
and frozen at − 80 °C until DNA extraction.
Collection of swab samples using Levine method
Swabs (Copan- Amies without charcoal M40 transystem
Interpath Services, Heidelberg West Victoria, Australia)
were collected from all DFUs using the Levine method,
which involves rotating the swab over a normal saline
cleansed area of 1 cm2 for 5 s and applying enough pres-
sure to exude and collect fluid from the tissue onto the
swab [17, 47]. Swab samples were collected from an area
close to the edge of the ulcer from where tissue biopsy
samples were collected from study participants. All swab
samples were frozen at − 20 °C during transport to and
storage at Southern Cross University Lismore N.S.W.
before DNA extraction.
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Extraction of DNA
Slightly different procedures were used for extraction of
bacterial DNA from tissue biopsies and swab samples in
order to maximise the recovery of pathogens according
to the nature of the sample. For both types of samples,
bead-beating was used prior to extraction to maximise
the ability to extract DNA out of the cellular material.
However, the lytic mixtures used were optimised for the
type of sample based on established protocols.
Extraction of DNA from tissue biopsies
Approximately 5–10mg of DFU tissue was defrosted on
ice prior to genomic DNA extraction using MoBio
Power Biofilm isolation kit (MoBio, Carlsbad, MA,
United States) as per manufacturer’s instructions. RNA-
later was removed using a sterile pipette. Briefly, the tis-
sue sample was added to a PowerBiofilm bead tube
containing 350 μl lysis solution and 100 μl of a chaotro-
pic solution and heated at 65 °C for 5 min. Bead tubes
were homogenised at 3200 rpm (940 g) or 53 Hz for 30 s
and centrifuged for 1 min at 11900 rpm (13,000 g) enab-
ling dissolution of the biofilm matrix and microbial cell
lysis using chemical and physical conditions. The super-
natant was transferred to a 2 ml collection tube, to
which was added a high salt solution and the mixture
poured through silica based spin filter and centrifuged.
The flow through was discarded. This step was repeated
and the DNA was eluted using sterile 10 mM Tris into a
clean 2 ml microtube. The extracted tissue biopsy DNA
samples were frozen and stored at − 20 °C.
Extraction of DNA from swabs
The following method was modified from a previously
described protocol [44]. Frozen swabs were thawed to
room temperature before extraction. A lytic mix was
prepared daily before extractions using the following
concentrations of enzymes: 25 μl of 20 mg/ml Lysozyme
(chicken egg white Sigma-Aldrich Australia cat.no.
L6876), 25 μl of 100 U/ml Mutanolysin (Streptomyces
globisporus ATCC 21553 Sigma-Aldrich Australia cat.no.
M9901), 20 μl of 40 μg/ml Lysostaphin (Staphylococcus
staphylolyticus Sigma Aldrich Australia cat.no. L7386)
and 930 μl DNase and RNase free water (Sigma-Aldrich,
Australia) to make a final volume of 1000 μl.
Thawed swab buds were each placed in sterile labelled
1.5 ml micro tubes containing 300 μl of DNase and
RNase free water (Sigma), 50 μl of lytic mix and incu-
bated at 37 °C for 30 min in a dry heating block. Each
swab was removed and the sample lysate centrifuged for
1 min at 1500 rpm (206 g). The sample lysate was asep-
tically transferred to a 2 ml bead beating tube containing
6 × 2.8 mm ceramic beads (Mobio, Carlsbad, MA, United
States cat. no.13114–325). Bead beating at 25 Hz (Qia-
gen Tissue Lyser 11, Hilden, Germany) for 1 min was
performed, after which the bead tubes were centrifuged
at 1200 rpm (132 g) for 1 min. The sample lysate from
the bead tube was aseptically transferred to a sterile 1.5
ml tube containing 200 μl Qiagen Buffer AL (QIAamp
extraction kit for blood and body fluids, Hilden,
Germany cat. no.51304) and vortexed for 10 s, after
which 20 μl of 20 mg/ml Proteinase K (QIAamp extrac-
tion kit for blood and body fluids) was added and the
sample lysate vortexed for another 15 s. The sample lysate
was incubated for 10min at 56 °C in a dry heating block
and centrifuged for 1min at 1500 rpm (206 g). Following
these steps, the procedure described in the QIAamp DNA
purification from Blood and Body fluids (spin protocol) in-
structions were followed from step 6 to step 10 and briefly
involved progressive ethanol washing (two steps) and cen-
trifugation using spin columns with silica membranes de-
signed to capture the DNA while proteins and other
contaminants were discarded with the ethanol in the fil-
trate. A further two steps involved washing the DNA in
buffer and discarding the buffer filtrate. Extracted DNA
samples were then incubated in 200 μl AE buffer at room
temperature for 5min before centrifuging at 8000 rpm
(5867 g) for 1min, as per manufacturers’ instructions to
increase DNA yields. The extracted swab DNA samples
were frozen and stored at − 20 °C.
The absorbance of the extracted tissue biopsy and
swab DNA at 260 nm and 280 nm was measured using
the Nanodrop 2000 (Thermo Fisher Scientific, Waltham,
Massachusetts, United States) and samples with a 260/
280 ratio of ≥1.3 were used for analysis.
Although different extraction kits were used for sam-
ples investigated in this study, the DNA extraction pro-
cedures for the tissue biopsy and swab samples were
based on similar principles. These procedures included
chemical and mechanical (bead beating) lysis of the bac-
terial cells, removal of cell debris including proteins and
polysaccharides, and use of a silica spin column to re-
cover sample bacterial DNA which was subsequently
washed and eluted. However the lytic mixtures differed
between the two extraction methods and the results are
interpreted with this in mind.
Quantitative PCR (qPCR) to determine bacterial
abundance and 16S/18S ratios
qPCR was carried out using a 25 μl reaction mixture
containing 1X Brilliant II Sybr Green qPCR Master mix
(Stratagene, San Diego, CA, Bacterial primers targeting
16S rRNA gene 341F (5′- CCTACGGGAGGCAGCAG
− 3′) and 534R (5′- ATTACCGCGGCTGCTGG − 3′),
to which 2 μl of extracted DNA template was added.
The cycling conditions were as follows: 95 °C for 10 min,
followed by 40 cycles of 95 °C for 15 s, 56 °C for 30 s and
72 °C for 30 s, using Stratagene MX 3000P (Agilent
Technologies, CA, United States). Each qPCR was run
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with genomic standards comprising 103–106 copies/μl
DNA extracted Staphylococcus aureus ATCC 25923. Mi-
crobial DNA free water (2 μl) (Qiagen Hilden Germany
cat.no.338132) was used as the negative template control
(NTC). The number of 16S rRNA gene copies/μl for
each sample was determined and used to calculate abun-
dance of bacteria in each sample. Genomic standards of
10 3–106 copies/μl of DNA extracted from fresh human
tissue were prepared to determine the number of copies
of the eukaryotic 18S rRNA gene, to ascertain the ratio
of human tissue in biopsies relative to that found in
swabs.
Bacterial community profiling
Extracted DNA from tissue biopsies and wound swabs
was sent to a commercial laboratory for analysis (Austra-
lian Centre for Ecogenomics, Brisbane, Australia), where
identical primers for both swabs and tissue were
employed for community profiling in the V4 region
(515F 5′- GTGYCAGCMGCCGCGGTAA − 3′ and
806wR 5′- GACTACHVGGGTWTCTAATCC-3′) [48]
modified to contain Illumina specific adaptor sequence:
(515F: 5′- TCGTCGGCAGCGTCAGATGTGT
ATAAGAGACAGGTGYCAGCMGCCGCGGTAA − 3′
and 803Rb: 5′- GTCTCGTGGGCTCGGAGATGTG
TATAAGAGACAGGACTACHVGGGTATCTAATCC
− 3′) The prokaryotic primer pair Prok SSU 515F 806Rb
amplifies the small subunit (SSU) ribosomal RNA of
bacteria and Archaea (16S), specifically the V4 region. In
Escherichia coli, it amplifies the 515–806 region of the
16S rRNA gene.
Preparation of the 16S library was performed as de-
scribed using the workflow outlined by Illumina (2013).
The PCR products of ~ 466 bp were first amplified ac-
cording to the workflow specified, but with substitution
of the polymerase to NEBNext® Ultra™ II Q5® Mastermix
(New England Biolabs #M0544). Agencourt AMPure XP
beads (Beckman Coulter) were used to purify the PCR
amplicons, which were then indexed with unique 8 bp
barcodes using the Illumina Nextera XT 384 sample
Index Kit A-D (Illumina FC-131-1002). Indexed ampli-
cons were pooled in equimolar concentrations and se-
quenced using paired end sequencing with V3 300bp
chemistry on a MiSeq Sequencing System (Illumina) in
the Australian Centre for Ecogenomics according to
manufacturer’s protocol.
Control reactions used for the amplicon library con-
struction and sequencing included:
– Positive control amplification of a mock community
to test for bias in the amplicon library construction.
– Negative amplicon control from a processed reagent
to test for potential contamination during library
construction.
– Empty chamber controls from single wells within
processing plates to test for potential cross
contamination within the library preparation.
– In line controls using negative index positions
between runs to test for any bleed through from run
to run.
Prior to data processing, resulting sequences with over
10,000 raw reads per sample were determined to pass
Quality Control (QC) and overall > 70% passed QC met-
rics of Q30 for 600 bp reads, in line with Illumina sup-
plied reagent metrics.
Sequence analysis
Raw sequencing data in FASTQ format was checked for
quality using the FastQC tool [49]. Trimmomatic soft-
ware (version 0.38) [50] was used to remove primer and
low quality sequences. Both paired end reads and for-
ward reads were generated from the Illumina MiSeq.
After quality control only the forward reads with > 200
bp lengths were retained for further analysis. Sequence
analysis was performed by means of the ACE mitag
pipeline which used QIIME (version 1.8) [51] and pick_
open_reference_OTUs.py workflow. UCLUST [52] clus-
tering algorithm was used to cluster the reads into oper-
ational taxonomic units (OTUs). Singletons and OTUs
with less than < 0.05% abundance were filtered out.
OTUs were BLAST searched against the Greengenes
chimera checked 16S rRNA gene reference database [53]
(version 2013/05) for 16S using ≥97% similarity score.
Statistical analyses
The DIVERSE function in PRIMER V7 version 7.0.13 +
PERMANOVA (PRIMER-E Ltd., Plymouth, UK) was
used to generate species richness (S), and Shannon’s di-
versity index (H) based on the reads data for each sam-
ple. Rarefaction of reads to 1500 was accepted to
provide a consistent depth of coverage. Samples with <
1500 reads were excluded from further analysis. Univari-
ate paired sample analyses were then undertaken using
GraphPad Prism version 7.02. The number of copies of
the 16S rRNA gene/μl was used to determine the bacter-
ial abundance in each sample. The number of reads and
bacterial abundance (qPCR) data did not pass D’Agos-
tino and Pearson normality tests, therefore, non-
parametric analyses using Wilcoxon signed-rank tests
were performed. Species richness data (number of dis-
tinct OTUs) and Shannon’s H index data passed normal-
ity testing and were analysed using parametric paired
sample t-tests. Spearman rank correlations were per-
formed between paired samples to establish whether
there was concordance in the order in which swab and
tissue samples were ranked for the number of reads, spe-
cies richness and Shannon’s H index. The dataset was
Travis et al. BMC Microbiology          (2020) 20:163 Page 11 of 14
filtered to select genera with known pathogens -namely
Staphylococcus spp., Streptococcus spp., Enterococcus
spp., Pseudomonas spp. and Corynebacterium spp., the
Enterobacteriaceae family, and members of the Clostri-
diales family XI (Finegoldia spp. and Anaerococcus spp.)
[10]. The mean relative abundance of reads in each of
these groups was square root transformed (sqrt) to re-
duce heterogeneity of variance and analysed using the
Wilcoxin signed rank test. Spearman rank correlation
was used for all groups. Results were considered signifi-
cant for p < 0.05. Comparison of the bacterial commu-
nity composition in swabs versus tissue samples was
undertaken using PRIMER V7 version 7.0.13 + PERMA-
NOVA. A Bray Curtis similarity matrix was constructed
from 4th root transformed data (to down-weight overly
abundant taxa), with a Dummy variable of 1. A one fac-
tor permutational analysis of variance (PERMANOVA)
was run to compare swabs and tissue samples, with 9999
permutations. Principle coordinate ordination plots were
used to graphically display the difference between swabs
and tissue samples, with vector overlay based on Pearson
correlation greater than 0.8. Dendograms were produced
from hierarchical cluster analysis to investigate the de-
gree of pairing in bacterial communities of samples
taken from the same DFU. To test for concordance in
the communities from the same DFU, separate similarity
matrices were prepared on the standardised swab and
tissue samples. The RELATE function was used to test
the matched resemblance matrices for paired samples
based on Spearman Rank correlation.
Positive and negative controls for tissue biopsies
Positive controls for the tissue biopsy method included
cultures of S. aureus and Acinetobacter rhizosphaerae
prepared to an O.D. of 0.03 at 600 λ absorbance. Dilu-
tions of S. aureus and of A. rhizosphaerae in 900 μl nu-
clease free water (Qiagen CAT No. / ID: 129114) were
prepared and extracted using the tissue extraction
method described. Sequencing results are presented in
Supplementary Table S7 Additional File 5 and were used
to confirm or otherwise that reagent contamination was
not biasing results.
Negative control tissue biopsy method: Sequencing re-
sults indicated no contamination of the positive controls
(Supplementary Table S7 Additional File 5) and hence of
the extraction procedure. This result acted as a negative
control for the DNA extraction from tissue biopsies.
Positive and negative controls for swabs
Positive controls: Twenty four hour colonies of S. aureus
ATCC 29213 and Pseudomonas aeruginosa ATCC
27856 were prepared in nutrient broth (Biomerieux,
Australia) and diluted in DNase and RNase free water
(Sigma-Aldrich, Australia) to an O.D. of 0.03 using 600
λ absorbance. A 1:5 dilution of each control organism
was prepared using 250 μl DNase and RNase free water
(Sigma-Aldrich, Australia) and 50 μl of each control or-
ganism and extracted using the described DNA swab ex-
traction method. Sequencing results are presented in
Supplementary Table S8 Additional File 5 and were used
to confirm or otherwise that reagent contamination was
not biasing results.
Negative controls to detect any sample collection swab
contamination were prepared with an unused thawed
frozen Copan swab and extracted using the described
swab procedure. Sequencing results are presented in
Supplementary Table S9 and Supplementary Table S10
Additional File 5 and were used to confirm or otherwise
that swab contamination was not biasing results.
Negative controls to detect reagent contamination with
no added sample were performed for the swab DNA ex-
traction method with reagents only and followed the rele-
vant DNA extraction procedures with 300 μl of DNase
and RNase free water (Sigma-Aldrich, Australia) and 50 μl
of lytic mix placed in a sterile 1.5 ml microtube and the
swab DNA extraction procedure followed exactly. Sequen-
cing and summarised results are presented in Supplemen-
tary Table S9 and Supplementary Table S10 Additional
File 5 and were used to confirm or otherwise that swab
and/or reagent contamination was not biasing results.
Quantitative PCR results for swab controls are presented
in Supplementary Table S11 Additional File 5.
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